Cencora, Inc. announced on January 23, 2025, the election of Frank K. Clyburn as a new independent director to its Board of Directors, effective October 1, 2024. Mr. Clyburn brings decades of executive experience, including from leading pharmaceutical manufacturers.
Additionally, Kathi Hyle and Dick Gochnauer are retiring from the Board at the upcoming annual meeting. Both individuals have been recognized for their significant contributions to Cencora's growth and success during their tenures.
These changes reflect the Board's ongoing commitment to effective, independent oversight and strategic planning. If all nominees are elected at the annual meeting, the Board will consist of 11 members, with eight being independent.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.